Background and objective: Telerehabilitation has the potential to increase access to pulmonary rehabilitation (PR) for patients with COPD who have difficulty accessing centre-based PR due to poor mobility, lack of transport and cost of travel. We aimed to determine the effect of supervised, home-based, real-time videoconferencing telerehabilitation on exercise capacity, self-efficacy, health-related quality of life (HRQoL) and physical activity in patients with COPD compared with usual care without exercise training. Methods: Patients with COPD were randomized to either a supervised home-based telerehabilitation group (TG) that received exercise training three times a week for 8 weeks or a control group (CG) that received usual care without exercise training. Outcomes were measured at baseline and following the intervention. Results: Thirty-six out of 37 participants (mean AE SD age = 74 AE 8 years, forced expiratory volume in 1 s (FEV 1 ) = 64 AE 21% predicted) completed the study. Compared with the CG, the TG showed a statistically significant increase in endurance shuttle walk test time (mean difference = 340 s (95% CI: 153-526, P < 0.001)), an increase in self-efficacy (mean difference = 8 points (95% CI: 2-14, P < 0.007)), a trend towards a statistically significant increase in the Chronic Respiratory Disease Questionnaire total score (mean difference = 8 points (95% CI: −1 to 16, P = 0.07)) and no difference in physical activity (mean difference = 475 steps per day (95% CI: −200 to 1151, P = 0.16)). Conclusion: This study showed that telerehabilitation improved endurance exercise capacity and self-efficacy in patients with COPD when compared with usual care.
INTRODUCTION
Pulmonary rehabilitation (PR) is a first line management strategy in patients with COPD as it reduces breathlessness, increases exercise capacity and improves health-related quality of life (HRQoL).
1,2 A small but significant increase in physical activity in patients with COPD has also been shown following PR. 3 However, 8-50% of those referred to PR never attend, whilst 10-32% of those who commence do not complete the programme. 4 Barriers to attendance and completion include difficulty accessing the programme, poor mobility, lack of transport and cost of travel. 5 Home-based PR may overcome the barriers to attendance at a centre-based programme. Home-based PR resulted in significantly greater improvements in exercise capacity and HRQoL compared with usual care in patients with COPD 1 and these improvements were similar to those demonstrated with centre-based programmes. 6 An alternative approach to delivery of supervised home-based PR is telerehabilitation, which is defined as the delivery of rehabilitation services using telecommunication technologies 7 such as realtime videoconferencing.
While there have been a number of telerehabilitation studies in COPD, [8] [9] [10] [11] [12] [13] [14] [15] the type of telecommunication strategies used have differed across studies. Two pilot randomized controlled trials (RCTs) have compared a web-based exercise programme with smartphone activity coaching, self-management education and teleconsultations to a control group (CG) of usual care. 8, 9 Results indicated a positive improvement in activity levels with high compliance to the activity coach, 8 and high satisfaction but low adherence with the exercise programme. 9 Other pilot studies where the home exercises have been supervised using real-time videoconferencing facilities have reported that programmes were safe, feasible and well accepted [11] [12] [13] [14] [15] by patients with COPD with a high adherence rate 13 and significant improvements in exercise capacity [12] [13] [14] and HRQoL. 12 Only one study has compared telerehabilitation with outpatient PR in patients with COPD. 10 This study was not an RCT and the telerehabilitation involved unsupervised home exercise training with telemonitoring support and periodic video assistance for support to exercise. The telerehabilitation group (TG) demonstrated improved physical activity, exercise capacity and dyspnoea equivalent to the outpatient PR group. 10 No studies have explored the effects of home-based telerehabilitation supervised using real-time videoconferencing facilities on exercise capacity, physical activity and HRQoL in a RCT for patients with COPD. The primary aim of this study was to determine, in patients with COPD, the effects of a supervised, home-based, real-time videoconferencing telerehabilitation programme on endurance exercise capacity compared with usual care without exercise training. The secondary aim was to explore the effects of telerehabilitation on HRQoL, level of physical activity, functional performance, overall health status, anxiety and depression and self-efficacy compared with usual medical care in patients with COPD.
METHODS

Participants
Patients who were referred to a tertiary hospital PR programme in Sydney, Australia, with a primary medical diagnosis of stable COPD (forced expiratory volume in 1 s (FEV 1 )/forced vital capacity (FVC) <70% and FEV 1 < 80% predicted post-bronchodilator) were invited to participate in the study. Participants were recruited according to inclusion and exclusion criteria (Table S1 , Supplementary Information).
Study design
This study was a prospective, blinded (assessor and statistician) RCT. Participants were randomized by one of the investigators (L.L.Y.T.) using a computergenerated sequence (https://www-users.york.ac.uk/ mb55/guide/minim.htm) and concealed allocation to one of the two groups: TG who performed supervised exercise training via desktop videoconferencing or the CG who performed no exercise training. Randomization was stratified according to the distance walked in the 6-min walk test (6MWT) (i.e. 6-min walk distance (6MWD) > or ≤ 350 m) and the degree of airway obstruction (FEV 1 > or ≤ 50% predicted). The study was approved by the South Eastern Sydney Local Health District Human Research Ethics Committee (12/177) and registered on the Australia New Zealand Clinical Trials Registry (ACTRN12612001263886).
Intervention
Telerehabilitation group
During an initial home-visit prior to training, a laptop computer with an in-built camera (HP EliteBook 8560p, CA, USA), a stationary lower limb cycle ergometer (Tunturi, E60, Netherlands) and a finger-tip pulse oximeter (Nonin Onyx Vantage 9590, MN, USA.) were delivered to the participant's home by an experienced physiotherapist for use in the home environment for the duration of the study. Participants were provided with a booklet and a face-to-face education session on how to use the equipment.
Telerehabilitation was conducted as supervised group exercise training only, three times a week for 8 weeks. The same physiotherapist who was based in the hospital supervised up to four participants remotely exercising at home in each session using real-time desktop videoconferencing software (VSee, CA, USA, http://vsee.com). Participants could see and talk to both the physiotherapist and the other participants. All participants performed lower limb cycle ergometry, walking training and strengthening exercises. Details on the duration, intensity, progression and monitoring of the exercises can be found in Table S2 (Supplementary Information). Compliance with telerehabilitation sessions was recorded by the number of completed exercise training sessions as prescribed out of a possible 24 sessions.
Control group
The CG received usual medical management including optimal pharmacological intervention and an action plan was provided. This group did not participate in any exercise training.
No formal education programme was provided to either group.
Outcome measures
Participants attended two visits at the hospital within a 7-day period at both baseline and immediately postintervention to undergo the following measurements which were performed by a research assistant who was blind to group allocation.
Pulmonary function test
Spirometry (FEV 1 and FVC), diffusing capacity of the lung for carbon monoxide (DL CO ) and static lung volumes by body plethysmography were performed according to the guidelines. [16] [17] [18] Disease severity of each participant was classified according to the GOLD (Global Initiative for Obstructive Lung Disease) spirometric criteria. 19 
Exercise test
Exercise capacity was assessed by the 6MWT, the incremental shuttle walk test (ISWT) and the endurance shuttle walk test (ESWT) according to standardized protocols. [20] [21] [22] The primary outcome measure was endurance exercise capacity, measured by the ESWT. Two tests were performed for each walk test over two visits within 7 days of each other, separated by at least 30-min rest. The better test result was used in the analysis. SpO 2 (peripheral capillary oxygen saturation) and heart rate (HR) were continuously monitored with a pulse oximeter (Masimo-Rad-5v, Masimo Corporation Irvine, CA, USA). Dyspnoea and rate of perceived exertion (RPE) were assessed before and after each exercise test using the modified 0-10 point Borg category-ratio scale. 23 Reference values for the 6MWT were based on an Australian study of healthy individuals. 24 During the ESWT, SpO 2 , HR and dyspnoea were assessed at 1-min intervals in order to compare ratings at isotime. Isotime was defined as the shortest end time of either the preor the post-intervention ESWTs.
Quality of life
The Chronic Respiratory Disease Questionnaire (CRDQ) was used to measure HRQoL. The minimal important difference for the four domains in this questionnaire are 2.5 for dyspnoea, 2 for fatigue, 3.5 for emotional function, 2 for mastery and 10 for the total score. 25 
Physical activity
The SenseWear Armband (SWA) and the accompanying software (SenseWear Professional 8.0; BodyMedia, Pittsburgh, PA, USA) were used to measure physical activity. They contain a triaxial accelerometer validated for estimating energy expenditure in patients with 
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COPD. 26, 27 Participants wore the SWA on their left upper arm for 24 h per day for six consecutive days with the exception of time spent in any water-related activity. Total energy expenditure, steps, metabolic equivalents (METs) and active energy expenditure (energy expenditure > 3 METs) were measured every minute. An a priori criterion for the definition of a 'completer' for this outcome measure was at least 3 days of recorded measurements with ≥85% (20.5 h) wear time in each 24-h time period.
Physical performance
Physical performance was assessed using the Functional Performance Inventory -Short Form (FPI-SF) which evaluates functional performance in patients with COPD in six domains including body care, maintaining the household, physical exercise, recreation, spiritual activities and social interactions. 28 
Health status
COPD health status was assessed using the COPD Assessment Test (CAT) which quantifies the impact of COPD on well-being. 29 
Dyspnoea
Dyspnoea was assessed with the Modified Medical Research Council (MMRC) dyspnoea scale. The MMRC assesses dyspnoea as part of the BODE (BMI, airway obstruction, dyspnoea, exercise capacity) index which has been determined in this study. 30 
Psychological status
Anxiety and depression were measured using the Hospital Anxiety and Depression Scale (HADS). 31 
Self-efficacy
The Pulmonary Rehabilitation Adapted Index of SelfEfficacy (PRAISE) tool was used to measure selfefficacy. 32 
Sample size
There are uncertainties about the ESWT minimum clinically important difference (MCID) but a change of 120 s had been recommended for endurance tests. 33 Assuming a baseline SD for the ESWT of 108 s, 34 a total of 34 participants (17 per group) would provide 90% power at a 5% significant level (two-sided) to detect a minimum difference of 120 s in the ESWT between the TG and the CG.
Statistical analysis
Data were analysed using SPSS software (version 20 for Windows, IBM, New York, USA). A P-value of <0.05 was considered significant. Intention-to-treat analysis was conducted with no imputation of missing values. Analysis of covariance (ANCOVA) was used to conduct between-group comparisons of outcomes after adjusting for pre-intervention values. Uncertainty about the size of the mean differences between groups was quantified with 95% CIs. Within-group comparisons were examined using paired t-tests and described as mean differences with 95% CIs.
RESULTS
Of the 128 consecutive patients referred to PR with COPD, 37 were enrolled in the trial (Fig. 1) . Thirty-six participants completed the study as there was one death from an adverse reaction to a medication unrelated to the study. Baseline characteristics were similar between the two groups ( Table 1) . Compliance with exercise group attendance was high (mean AE SD = 22 AE 5 sessions). No adverse events occurred. Out of a total of 197 exercise training sessions, there were 24 technical issues (12%) related to the use of technology (e.g. poor internet connection).
TG training duration and intensity
Cycling and walking duration and intensity progression are shown in Table 2 .
Exercise capacity
In the TG, significant within-group improvements in ESWT time and 6MWD were demonstrated following training (Table 3) . Compared with the CG, the TG demonstrated significantly greater improvements in ESWT time. There were no within-group or betweengroup improvements in ISWT distance (Table 3 ). There were no statistically significant between-group differences for SpO 2 , HR or dyspnoea at isotime during the ESWT (Table 4) .
Quality of life
Within-group analyses showed a significant improvement in CRDQ total score for the TG following training (Table 3) . Compared with the CG, the TG demonstrated a trend towards a significant improvement in CRDQ total score of 8 points (95% CI: −1 to 16, P = 0.07). No significant between-group differences were shown for the CRDQ domains.
Physical activity
There were no statistically significant between-group differences for any of the physical activity measures (Table 5) .
Physical performance
There were no statistically significant between-group differences in the FPI-SF score (Table 3) .
Health status
There were no statistically significant between-group differences in the CAT score (Table 3) .
Psychological status
Compared with the CG, the TG demonstrated a significant improvement in both anxiety and depression scores (Table 3) .
Self-efficacy
Compared with the CG, the TG demonstrated a significant improvement in PRAISE scale (Table 3) .
DISCUSSION
This is the first RCT in patients with COPD examining the effects of home-based telerehabilitation with supervision of all exercise sessions using real-time videoconferencing. The main findings were that, directly following telerehabilitation, there was a significant improvement in endurance exercise capacity and selfefficacy and a trend towards improvement in HRQoL when compared with usual medical care.
The between-group difference for the ESWT of 340 s surpasses the MCID for ESWT which has been reported as 180 s. 34 The between-group difference is also similar (11) to that reported in an official ERS statement 35 where the pooled effect of PR on ESWT was approximately 360 s. While there was no statistically significant difference in the 6MWD between groups, the treatment effect of 45 m favouring the TG indicated a clinically relevant effect as it surpassed the MCID for the 6MWD of 30 m. 36 There was no significant between-groups difference in the distance walked in the ISWT indicating a lack of improvement for peak exercise capacity. Small non-randomized trials of telerehabilitation in patients with COPD have shown increases in 6MWD ranging between 27 and 54 m. 10, [12] [13] [14] Our study extends these findings using RCT methodology with comprehensive measures of functional, peak and endurance exercise capacity.
The exercise prescription in this study aimed to reflect typical supervised centre-based programmes. Supervision was provided by a physiotherapist experienced in PR enabling continuous monitoring and progression in exercise intensity and duration. The intensity of cycle training was set at 60% peak work and walking training at 80% of peak walking speed from the best 6MWT result. Previous research has indicated physiological improvements with these intensity levels. 37, 38 By the end of the 8-week programme, all participants were able to achieve the initial cycle training intensity and 78% of participants were able to achieve the initial walk training intensity. The major limitation for progression in cycle training was leg fatigue and/or breathlessness and for walking training was chronic hip or back pain. Despite these symptom limitations to training, the supervision and group focus of the telerehabilitation programme may have assisted participants with the good adherence to training intensity.
The secondary outcome of HRQoL was measured by the CRDQ. For both the total score and the individual domain scores, there was no significant between-group difference. However, a clinically relevant effect in the dyspnoea and fatigue domains was shown. Other (7) 18 (8) 19 (5) 17 (6) 2.2 (−0.1 to 4) −1 (−5 to 3) 2.8 (−0.5 to 6.1) 0.09 Fatigue 15 (5) 15 (7) 18 (6) 15 (7) (9) 33 (9) 39 (5) 36 (8) 4 (1 to 7) † 2 (−1 to 6) 2.7 (−0.7 to 6.1) 0.12 Mastery 22 (4) 21 (5) 23 (5) 22 ( (7) 15 (6) 15 (7) 18 ( (9) 46 (9) 50 (6) 42 ( (13) 66 (14) 66 (14) 64 (15) 0.4 (−5 to 6) −2 (−6 to 3) 2.0 (−4.8 to 8.8) 0.55 Body care
13 (2) 14 (2) 14 (1) 14 (2) Data are presented as mean (SD) unless otherwise stated. Sample number was n = 19 in TG and n = 17 in the CG. † Significant difference within-group paired t-test (P < 0.05). ‡ Significant difference between groups from ANCOVA adjusting follow-up measures for baseline measures (P < 0.05). § Higher score in CRDQ, PRAISE and FPI-SF equates to better outcome. ¶ Lower score in CAT and HADS equates to better outcome. 6MWT, 6-min walk test; ANCOVA, analysis of covariance; CAT, COPD Assessment Test; CG, control group; CI, confidence interval; CRDQ, Chronic Respiratory Disease Questionnaire; ESWT, endurance shuttle walk test; FPI-SF, Functional Performance InventoryShort Form; HADS, Hospital Anxiety and Depression Scale; ISWT, incremental shuttle walk test; MD, mean difference; PRAISE, Pulmonary Rehabilitation Adapted Index of Self-Efficacy; SD, standard deviation; TG, telerehabilitation group. telerehabilitation studies using supervised videoconferencing programmed have also shown improvements in dyspnoea [12] [13] [14] and HRQoL. 10, [12] [13] [14] Despite the lack of clear effect of telerehabilitation on HRQoL, a positive effect was shown on self-efficacy as measured by the PRAISE tool and on symptoms of anxiety and depression as measured by the HADS. An increase in self-efficacy enables positive emotional functioning and improved coping skills. These selfefficacy improvements may have been a result of the use of technology empowering patients with COPD to improve management of their disease. The improvements in self-efficacy of the TG were particularly remarkable given that 32% of participants had never used a computer before. Our study indicates that it is feasible to provide telerehabilitation to patients with COPD who have no prior computer experience.
Physical activity did not show any between-group statistical differences following telerehabilitation. This result concurs with the current literature showing that exercise training has only a small effect on daily physical activity in patients with COPD. 4 It is possible that exercise training alone is not enough to improve activity levels and that other interventions need to be trialled that have a specific activity focus.
A positive result in this study was the low dropout rate (only one participant) and the high compliance with exercise training. This is in contrast to another telerehabilitation programme, which was not supervised using real-time videoconferencing, where poor adherence to exercise was reported. 8 Furthermore, centrebased PR programmes also reported higher dropout rates and poor compliance rates, 39 often due to difficulty accessing the venue. 5 In the current study, telerehabilitation overcame these access issues by allowing supervision of exercise training in the home environment and providing flexibility with the time of training sessions. The constant supervision provided by the physiotherapist during all exercise sessions and the fact that participants exercised in a virtual group setting may have motivated participants to be compliant with training. Telerehabilitation could be a worthwhile alternative training mode for patients who are able to manage technology at home but are unable or unwilling to attend centre-based PR programmes.
A limitation of this study was the small sample size which was powered according to the ESWT. This may account for why some secondary outcomes, such as HRQoL, only showed a trend towards a significant difference between groups, despite showing symptom effects which were clinically relevant. The study also did not include patients utilizing home oxygen, those with limited exercise tolerance who were housebound or patients not interested in using a computer. Patients with very severe COPD (GOLD IV) were also not represented in this sample (although it was not an exclusion criteria). Therefore, the external validity of the study is limited as findings cannot be generalized to these groups. In addition, some patients in this cohort had completed PR previously (63%) which may have made it easier for them to undertake telerehabilitation. We also did not offer comprehensive telerehabilitation with education so this requires further evaluation. Finally, this study did not include a long-term follow-up which would be important to examine in future studies.
In conclusion, a supervised, home-based, real-time videoconferencing telerehabilitation exercise programme was effective in increasing endurance exercise capacity and self-efficacy in patients with COPD. This type of telerehabilitation provides an alternative option of delivery of PR for patients with COPD and may be particularly useful for those who have difficulty attending centre-based programmes. of Wales Hospital, Randwick, Australia) for their assistance with respiratory function testing; Professor Anne Holland (Department of Rehabilitation, Nutrition and Sport, La Trobe University, Melbourne, Australia) for her advice on the utilization of VSee videoconferencing software; Professor Jennifer Peat (Australian Catholic University, North Sydney, Australia) for review and advice on statistical analysis; the staff of the SWA total time worn (days)
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